Impact of D-dimer levels for short-term or long-term outcomes in cryptogenic stroke patients
- 25 January 2018
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 265 (3) , 628-636
Abstract
D-dimer levels are used in several clinical settings, such as in predicting venous thrombosis, cardioembolic stroke and cancer status. In the present study, we investigated the associations between plasma D-dimer levels at admission, clinical characteristics and mortality at discharge in cryptogenic stroke patients. We also investigated whether D-dimer levels can predict long-term outcomes in those patients, including those with and without right-to-left shunt (RLS).Keywords
Funding Information
- JSPS KAKENHI (17K17907)
This publication has 30 references indexed in Scilit:
- Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI studyHaematologica, 2013
- Association between Serum Interleukin-6 Concentrations and Mortality in Older Adults: The Rancho Bernardo StudyPLOS ONE, 2012
- Stroke Subtype Classification to Mechanism-Specific and Undetermined Categories by TOAST, A-S-C-O, and Causative Classification SystemStroke, 2010
- Detection of Right‐to‐Left Shunts may be Associated with Body SizeJournal of Neuroimaging, 2010
- Etiologic Diagnosis of Ischemic Stroke Subtypes With Plasma BiomarkersStroke, 2008
- Ischaemic stroke with malignancy may often be caused by paradoxical embolismJournal of Neurology, Neurosurgery & Psychiatry, 2006
- D-dimer is not a long-term prognostic marker following acute cerebral ischemiaBlood Coagulation & Fibrinolysis, 2006
- Inflammation-Mediated Damage in Progressing Lacunar InfarctionsStroke, 2002
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Paradoxical embolism: Clinical presentation, diagnostic strategies, and therapeutic optionsAmerican Heart Journal, 1986